ALB and lung cancer: The C-reactive Protein to Albumin Ratio has been demonstrated to predict unfavorable outcomes in colorectal cancer, oral squamous cell carcinoma, gallbladder cancer, lung cancer, and thoracic esophageal cancer (33–37).